Position in AZN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$10,231,895
+$7,939,213 QoQ
Shares Held
53,960
+364.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#303
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STEPHENS INC /AR/ holds $244,605,118 across 14 Drug Manufacturers - General names. AZN ranks #7 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
210,285 | $53,406,081 | |
| 2 | LLY |
ELI LILLY & Co
|
37,094 | $44,491,660 | |
| 3 | MRK |
Merck & Co., Inc.
|
272,973 | $35,077,030 | |
| 4 | ABBV |
AbbVie Inc.
|
139,208 | $35,030,301 | |
| 5 | AMGN |
Amgen Inc
|
93,841 | $33,981,702 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
282,306 | $16,266,471 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
53,960 | $10,231,895 | |
| 8 | PFE |
Pfizer Inc
|
335,032 | $8,067,570 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,231,895 | 53,960 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $2,292,682 | 11,625 | Shares | Defined | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||